Process for the preparation of trans-3-formylbut-2-enenitrile
AssigneeAlberta Research Council
InventorsShi-Chow Chen, John M. MacTaggart
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlberta Research Council
InventorsShi-Chow Chen, John M. MacTaggart
Estimating the term…
A process is provided for the preparation of trans-3-formylbut-2-enenitrile (V), a key intermediate in the synthetic pathway leading to trans-zeatin (I) and dihydrozeatin (II), both of which are naturally occurring cytokinins. The process involves a base catalyzed condensation of a dialkyl or cyclic acetal of pyruvaldehyde (III) with acetonitrile to yield the corresponding dialkyl or cyclic acetal of 3-formylbut-2-enenitrile (IV). The reaction proceeds regioselectively to form the favored trans-isomer in good yield. The .alpha.,.beta.-unsaturated nitrile thus formed is hydrolyzed under acidic conditions to yield trans-3-formylbut-2-enenitrile (V), which can be easily distilled without contamination of the cis-isomer. The trans-3-formylbut-2-enenitrile can be selectively or exhaustively reduced to form either trans-3-hydroxymethylbut-2-enylamine (VI) or 3-hydroxymethylbutylamine (VII), which compounds can be condensed with 6-chloropurine (IX) by known methods to form trans-zeatin or dihydrozeatin respectively.
The process comprising:
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
No related US applications are recorded in the indexed filing history.
Carboxylic acid nitriles
1,3-Dioxanes; Hydrogenated 1,3-dioxanes: not condensed with other rings
Acyclic or carbocyclic compounds
Heterocyclic compounds
Term ended 21 Jan 2000 (estimated)
USPTO file history isn’t available for this patent, so only indexed dates are shown.
The present invention relates to processes for the production of key intermediates in the synthetic pathway leading to naturally occurring cytokinins, particularly trans-zeatin and dihydrozeatin.
Cytokinins are naturally occurring 6-substituted aminopurines, which are plant hormones known for their biological activity on plant growth. The more important of these effects are the abilities to induce cell division and regulate differentiation in excised plant tissue. Zeatin is one of the most active forms of the cytokinins.
Owing to the difficulty in isolating even minute quantities of the naturally occurring cytokinins, researchers have turned their efforts to investigating synthetic pathways to form biologically active 6-substituted aminopurines. For trans-zeatin, much of the research has been focused on a suitable synthesis of trans-3-hydroxymethylbut-2-enylamine (VI), the highly functionalized unsaturated side chain which can be condensed, by known methods, with 6-chloropurine to form trans-zeatin. In the case of dihydrozeatin (II), the desired side chain is 3-hydroxymethylbutylamine (VII).
FIGS. 1A and 1B are formula sheets showing structural formulas and names for the compounds referred to in the specification; and
FIG. 2 is a reaction sheet showing an example of the reactions described in the specification.
The present invention involves a base catalyzed condensation of a pyruvaldehyde acetal with acetonitrile to form the corresponding acetal of 3-formylbut-2-enenitrile, which is subsequently hydrolyzed in acidic conditions to form trans-3-formylbut-2-enenitrile. FIG. 2 shows the reactions involved in the present invention starting from pyruvaldehyde dimethyl acetal.
A large number of pyruvaldehyde acetals are suitable as a starting material for the process. Generally the structural formula for the pyruvaldehyde acetal is ##STR2## where R is an alkyl, cycloalkyl, substitued alkyl or alkenyl group, having from about 1-10 carbon atoms, or R is a methylene group in a polymethylene chain --(CH.sub.2).sub.n -- in a cyclic acetal having a 5-10 membered ring structure. Thus the general formula as given is meant to represent both subtituted acetals, such as pyruvaldehyde dimethyl acetal, and cyclic acetals such as 2-acetyl-1,3-dioxan.
A number of pyruvaldehyde acetals are commercially available, however they can also be prepared by reacting 1,3-dihydroxy-2-propanone with monohydric or dihydric alkanols by, for example, the method of S. K. Gupta, J. Org. Chem., 41, 2642, 1976.